Nicolas Sitchon
Amministratore Delegato presso S1 BioPharma, Inc.
Profilo
Nicolas Gomez Sitchon is currently the Chairman, President & Chief Executive Officer at S1 BioPharma, Inc. He has been in this position since 2010.
He has a graduate degree from Boston University School of Medicine and an MBA from Questrom School of Business.
Posizioni attive di Nicolas Sitchon
| Società | Posizione | Inizio |
|---|---|---|
S1 BioPharma, Inc.
 S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Amministratore Delegato | 01/10/2010 |
Formazione di Nicolas Sitchon
| Boston University School of Medicine | Graduate Degree |
| Questrom School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
S1 BioPharma, Inc.
S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Nicolas Sitchon
